/Investor DB

Amzak Health — Full Portfolio

31 tracked investments · listed companies and verified rows first

4D Molecular Therapeutics4dmoleculartherapeutics.cominNASDAQ: FDMTJun 2020 · $75M

4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.

BiotechHealthtechEmeryville, US

David Kirn(Chief Executive Officer, President, and Co-Founder)inDavid Schaffer(Director)inTheresa Janke(Chief of Staff, Co-Founder)in

BoardSharon Tetlow(Director)Margi McLoughlin(Director)

Co-investorsBerkeley CatalystBOLD LongevityCasdin CapitalChiesi VenturesHercules Capital, Inc.Pappas Capital+8 more

Monte Rosa Therapeuticsmonterosatx.comin𝕏NASDAQ: GLUE

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Markus Warmuth(Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in

Co-investorsAisling CapitalHBM PartnersNew Enterprise Associates (NEA)Versant VenturesAvoro Capital AdvisorsGV (Google Ventures)+4 more

Teleflexteleflex.comNYSE: TFX

Teleflex is a medical device company.

Medical Devices

Stuart A. Randle(Interim President and Chief Executive Officer; Director)

Lqttrxlqttrx.comin𝕏✓ verified

Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.

BiotechHealthtechMedical Devices

Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinAmy Sehnertin

Co-investorsadMare BioInnovationsAlexandriaCTI Life Sciences Fund L.P.Lumira Ventures

Thryvthryvtrx.comin𝕏✓ verified

Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).

BiotechDigital HealthMedical Devices

Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in

BoardSaumya Das(Chief Scientific Advisor)

Co-investorsadMare BioInnovationsLumira VenturesCTI Life Sciences Fund L.P.Fonds de solidarité FTQ

Antios Therapeuticsantiostherapeutics.comin𝕏Nov 2021 · $75M

Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.

BiotechHealthtechMendham, US

Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)inTamra Adams(Executive Officer)inAbel De La Rosa(Director)

BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)

Co-investorsAisling CapitalAltium CapitalAvego BioScience CapitalLifeSci Venture PartnersPontifax Venture CapitalDelos Capital+8 more

Bridgebiobridgebio.comin𝕏

BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support.

BiotechHealthtech

Neil Kumar(Founder)

Co-investorsAisling CapitalEcoR1 CapitalFrazier Life SciencesHEALTHCARE ROYALTY PARTNERSHercules Capital, Inc.Longwood Fund+3 more

Contego Medicalcontegomedical.comin

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.

HardwareHealthtechMedical DevicesRaleigh, US

Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)

Co-investorsHatteras Venture PartnersLightstone VenturesMountain Group CapitalUS Venture Partners

Eidos Therapeuticseidostx.com𝕏Mar 2018Acquired

A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.

BiotechDigital HealthHealthtechSan Francisco, US

NEIL KUMAR(Executive Officer, Director)JONATHAN FOX(Executive Officer)UMA SINHA(Executive Officer)CHRISTINE SIU(Executive Officer)HOYOUNG HUH(Director)ERIC AGUIAR(Director)

Co-investorsAisling CapitalForesite CapitalHercules Capital, Inc.RA CapitalViking GlobalViking Global Investors

Gynesonicsgynesonics.com𝕏Oct 2023 · $43Macquired by Hologic

FemTechHealthtechMedical DevicesRedwood City, US

Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)

BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)

Co-investorsBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz VenturesLightstone Ventures+6 more

HistoSonicshistosonics.comin𝕏

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.

BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB

Thomas Davison(Executive Officer, Director)inM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)

Co-investorsAlpha JWC VenturesAlpha Wave GlobalArboretum VenturesClarevia VenturesEarly Stage Partners, LPHatteras Venture Partners+9 more

Impulse Dynamicsimpulse-dynamics.comin𝕏Dec 2019 · $80M

Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.

BiotechHardwareHealthtechMedical DevicesDublin 2, US

Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in

Co-investorsWellington ManagementAlgerBraidwellEssex Woodlands Healthcare PartnersREDMILESands Capital Ventures+1 more

InnoVeininnoveinmedical.com𝕏Series ADefunct

InnoVein develops a replacement valve for veins intended to treat chronic, hard-to-heal leg wounds.

BiotechGamingHealthtechMarketplacesMedical DevicesSan Francisco, US

Austin Walker(Founder/CEO)inAl Chin(Founder)inTom Kramer(Founder)inThomas Harold Pierce(Executive Officer, Promoter)

Co-investorsHemisphere Ventures LLCPallasite VenturesStartXY CombinatorAgrolimen VenturesAvlok Capital+10 more

Inspire Medicalinspiresleep.comin𝕏Oct 2016 · $38M

Inspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective.

Digital HealthHealthtechMedical DevicesGolden Valley, US

Tim Herbert(Founder)in

BoardMudit Jain(Director)Joyce Erony(Director)inDana Mead(Director)Chau Khuong(Director)inCasey Tansey(Director)

Co-investorsAPERTURE Venture PartnersUS Venture PartnersOrbiMed

KOKO Medical Inc.kokomed.comin

KOKO Medical is a development-stage medical device startup building a catheter-based device that encourages uterine contractions and removes excess blood to treat postpartum hemorrhage.

FemTechHealthtechMedical DevicesExton, US

Skott Greenhalgh(Co-Founder, Chief Executive Officer)inMichael Wallace(Co-Founder, Chief Technology Officer)inJason Keiser(Co-Founder, VP of Operations)in

MEI Pharmameipharma.comin𝕏May 2018 · $75M

Lite Strategy, Inc.

BiotechCrypto & Web3FintechHealthtechSan Diego, US

David M. Urso(Executive Officer)inDaniel P. Gold(Executive Officer, Director)Brian G. Drazba(Executive Officer)inMr. File(Chief Executive Officer & Board Member (former CFO))Justin (Jay) File(CEO, CFO)inKevan E. Clemens(Director)

Co-investors3B Future Health FundAisling CapitalGSRNew Enterprise Associates (NEA)Primitive VenturesBiotechnology Value Fund+1 more

Miach Orthopaedicsmiachortho.cominSeries B · Jan 2023 · $30M

Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears.

HealthtechMedical DevicesWestborough, US

Martha Murray(Founder)inChris Joyce(Executive Officer)inPatrick McBrayer(Executive Officer, Director)inSean Sansiveri(Director)Pieter Wolters(Director)

BoardMarc-Andre Marcotte(Director)

Co-investorsAPERTURE Venture PartnersEndeavour VisionSV Health Investors

Nervoniknervonik.cominApr 2026 · $52.5M

Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.

HardwareHealthtechMedical Devices

Co-investorsFoothill VenturesJoyance PartnersLumira VenturesShangBay Capital LLCUS Venture PartnersU.S. Venture Partners

Neuros Medicalneurosmedical.comSeries B · Jul 2025 · $56M

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in

BoardJoyce Erony(Director)inWilliam Harrington(Director)in

Co-investorsAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+5 more

NuXcelnuxcel.comOct 2024 · $66M

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.

Deep TechHealthtechMedical Devices

Co-investorsTreo Ventures, LlcAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners

Reneoreneo.deinDec 2020 · $95M

Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.

Climate TechEnterprise SoftwarePropTechGermany, DE

Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in

Co-investorsFoundamentalAbingworthAisling CapitalEurazeoLakestarLundbeckfonden Ventures+4 more

Reneo Pharmaceuticalsreneopharma.comDec 2020 · $95M

Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.

ConsumerMedia & EntertainmentSports Tech

Co-investorsAisling CapitalChiesi VenturesNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersAbingworth+3 more

ShiraTronicsshiratronics.cominSeries A · Sep 2024 · $66M

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.

BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US

Robert Binney(Executive Officer, Director)

BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in

Co-investorsAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more

Sound Blade Medicalsoundblademedical.comMar 2025

SoundBlade Medical develops handheld histotripsy technology for non-invasive surgery, using focused ultrasound to treat tissue with precision.

HardwareHealthtechMedical Devices

Jeremy Brown(Co-Founder & CTO)inMatt Mallay(Co-Founder & Sr. Dir. R&D)inAndre Bezanson(Co-Founder & Dir. R&D)inEli Vlaisavljevich(Co-Founder)inRick Balys(Co-Founder)inNeil Barman(Chief Executive Officer)in

Co-investorsLumira VenturesAPERTURE Venture PartnersInvest Nova Scotia

Synergysynergy.marketsFeb 2024 · $30M

Synergy is a social trading platform (in beta) where users find and follow traders, whales, and KOLs, track trending market metas, and trade together in a multiplayer mode.

Crypto & Web3FintechSocial

Co-investorsBitDAOMantle Network

Synergy Disc Replacementsynergy-disc.comSeries A · Jan 2024 · $30M

Synergy Disc is a medical device company developing motion-preserving spine technologies to treat degenerative disc disease while supporting the spine's natural curvature.

HealthtechMedical Devices

Co-investorsLaurier Startup FundNorthspring Capital Partners

Synergy Spinesynergyspinesolutions.comin

Synergy Spine Solutions develops motion-preserving medical devices for patients undergoing spine surgery to treat degenerative disc disease.

HardwareHealthtechMedical Devices

Josh Butters(Chief Executive Officer)in

BoardSteve Farlow(Chairman)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Essential MedicalKEW GroupThryv TherapeauticsThryv Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.